These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Donor and recipient risk factors for the development of primary graft dysfunction following lung transplantation. Jenkins JA; Verdiner R; Omar A; Farina JM; Wilson R; D'Cunha J; Reck Dos Santos PA Front Immunol; 2024; 15():1341675. PubMed ID: 38380332 [TBL] [Abstract][Full Text] [Related]
7. Primary graft dysfunction: pathophysiology to guide new preventive therapies. Shaver CM; Ware LB Expert Rev Respir Med; 2017 Feb; 11(2):119-128. PubMed ID: 28074663 [TBL] [Abstract][Full Text] [Related]
8. Primary graft dysfunction after lung transplantation. Hunt ML; Cantu E Curr Opin Organ Transplant; 2023 Jun; 28(3):180-186. PubMed ID: 37053083 [TBL] [Abstract][Full Text] [Related]
10. Graft dysfunction immediately after reperfusion predicts short-term outcomes in living-donor lobar lung transplantation but not in cadaveric lung transplantation. Mizota T; Miyao M; Yamada T; Sato M; Aoyama A; Chen F; Date H; Fukuda K Interact Cardiovasc Thorac Surg; 2016 Mar; 22(3):314-20. PubMed ID: 26705301 [TBL] [Abstract][Full Text] [Related]
12. Quantitative Evidence for Revising the Definition of Primary Graft Dysfunction after Lung Transplant. Cantu E; Diamond JM; Suzuki Y; Lasky J; Schaufler C; Lim B; Shah R; Porteous M; Lederer DJ; Kawut SM; Palmer SM; Snyder LD; Hartwig MG; Lama VN; Bhorade S; Bermudez C; Crespo M; McDyer J; Wille K; Orens J; Shah PD; Weinacker A; Weill D; Wilkes D; Roe D; Hage C; Ware LB; Bellamy SL; Christie JD; Am J Respir Crit Care Med; 2018 Jan; 197(2):235-243. PubMed ID: 28872353 [TBL] [Abstract][Full Text] [Related]
13. Cell-free DNA in human ex vivo lung perfusate as a potential biomarker to predict the risk of primary graft dysfunction in lung transplantation. Kanou T; Nakahira K; Choi AM; Yeung JC; Cypel M; Liu M; Keshavjee S J Thorac Cardiovasc Surg; 2021 Aug; 162(2):490-499.e2. PubMed ID: 32928548 [TBL] [Abstract][Full Text] [Related]
14. Clinical risk factors for primary graft dysfunction after lung transplantation. Diamond JM; Lee JC; Kawut SM; Shah RJ; Localio AR; Bellamy SL; Lederer DJ; Cantu E; Kohl BA; Lama VN; Bhorade SM; Crespo M; Demissie E; Sonett J; Wille K; Orens J; Shah AS; Weinacker A; Arcasoy S; Shah PD; Wilkes DS; Ware LB; Palmer SM; Christie JD; Am J Respir Crit Care Med; 2013 Mar; 187(5):527-34. PubMed ID: 23306540 [TBL] [Abstract][Full Text] [Related]
15. Neutrophil extracellular traps are pathogenic in primary graft dysfunction after lung transplantation. Sayah DM; Mallavia B; Liu F; Ortiz-Muñoz G; Caudrillier A; DerHovanessian A; Ross DJ; Lynch JP; Saggar R; Ardehali A; ; Ware LB; Christie JD; Belperio JA; Looney MR Am J Respir Crit Care Med; 2015 Feb; 191(4):455-63. PubMed ID: 25485813 [TBL] [Abstract][Full Text] [Related]
16. Prolonged Cold Ischemia Induces Necroptotic Cell Death in Ischemia-Reperfusion Injury and Contributes to Primary Graft Dysfunction after Lung Transplantation. Wang X; O'Brien ME; Yu J; Xu C; Zhang Q; Lu S; Liang L; An X; McDyer JF; Mallampalli RK Am J Respir Cell Mol Biol; 2019 Aug; 61(2):244-256. PubMed ID: 30742487 [TBL] [Abstract][Full Text] [Related]
20. Soluble Adhesion Molecules During Ex Vivo Lung Perfusion Are Associated With Posttransplant Primary Graft Dysfunction. Hashimoto K; Cypel M; Kim H; Machuca TN; Nakajima D; Chen M; Hsin MK; Zamel R; Azad S; Waddell TK; Liu M; Keshavjee S Am J Transplant; 2017 May; 17(5):1396-1404. PubMed ID: 27977885 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]